Pages that link to "Q39920642"
Jump to navigation
Jump to search
The following pages link to ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. (Q39920642):
Displaying 50 items.
- Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action (Q24276089) (← links)
- Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals (Q26782033) (← links)
- Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection (Q26801381) (← links)
- The human ITPA polymorphic variant P32T is destabilized by the unpacking of the hydrophobic core (Q27677053) (← links)
- A disease spectrum for ITPA variation: advances in biochemical and clinical research (Q28069352) (← links)
- Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity (Q28083100) (← links)
- Pharmacogenomics: playing the odds (Q28240401) (← links)
- Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C (Q28254011) (← links)
- ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection (Q28606732) (← links)
- GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database (Q28657400) (← links)
- Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy (Q28729086) (← links)
- Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C (Q28943467) (← links)
- Computational neuroanatomy of speech production. (Q30360356) (← links)
- Rapidly improved determination of metabolites from biological data sets using the high-efficient TransOmics tool (Q30828421) (← links)
- Integrating functional data to prioritize causal variants in statistical fine-mapping studies (Q30865659) (← links)
- A novel approach for identifying causal models of complex diseases from family data (Q30896568) (← links)
- Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients (Q33395929) (← links)
- Interleukin28B and inosine triphosphatase help to personalize hepatitis C treatment (Q33398664) (← links)
- Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants (Q33404251) (← links)
- Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype (Q33404324) (← links)
- Platelet count and sustained virological response in hepatitis C treatment (Q33407719) (← links)
- Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection (Q33408167) (← links)
- Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. (Q33413296) (← links)
- Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report (Q33413883) (← links)
- Association between IPTA gene polymorphisms and hematological abnormalities in hepatitis C virus-infected patients receiving combination therapy (Q33418008) (← links)
- Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients (Q33429063) (← links)
- Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C. (Q33430028) (← links)
- Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis (Q33579196) (← links)
- A tool for mapping Single Nucleotide Polymorphisms using Graphics Processing Units (Q33588261) (← links)
- Involvement of MAP3K8 and miR-17-5p in poor virologic response to interferon-based combination therapy for chronic hepatitis C. (Q33599325) (← links)
- WWOX gene is associated with HDL cholesterol and triglyceride levels. (Q33717629) (← links)
- Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine (Q33725390) (← links)
- Host genetics and HIV-1: the final phase? (Q33728658) (← links)
- Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy (Q33815550) (← links)
- Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy (Q34008754) (← links)
- Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals (Q34137532) (← links)
- Single-Nucleotide Polymorphisms Within MicroRNAs Sequences and Their 3' UTR Target Sites May Regulate Gene Expression in Gastrointestinal Tract Cancers. (Q34197275) (← links)
- A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND. (Q34215485) (← links)
- Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy (Q34246440) (← links)
- Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C. (Q34334776) (← links)
- Predicting signatures of "synthetic associations" and "natural associations" from empirical patterns of human genetic variation (Q34335490) (← links)
- Clinical utility of pharmacogenomics in the management of hepatitis C. (Q34464613) (← links)
- Management of Hepatitis C Antiviral Therapy Adverse Effects (Q34538771) (← links)
- Leveraging prior information to detect causal variants via multi-variant regression (Q34769251) (← links)
- Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C (Q34805448) (← links)
- Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction (Q34913385) (← links)
- Pharmacogenomics of antimicrobial agents (Q34977413) (← links)
- Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients (Q34981566) (← links)
- Detection of common single nucleotide polymorphisms synthesizing quantitative trait association of rarer causal variants (Q35085288) (← links)
- Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving Telaprevir (Q35156156) (← links)